首页> 外文期刊>AJNR. American journal of neuroradiology >Treatment Response Prediction of Nasopharyngeal Carcinoma Based on Histogram Analysis of Diffusional Kurtosis Imaging
【24h】

Treatment Response Prediction of Nasopharyngeal Carcinoma Based on Histogram Analysis of Diffusional Kurtosis Imaging

机译:基于扩散峰成像的直方图分析的鼻咽癌治疗响应预测

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND PURPOSE: The prediction of treatment response is important in planning and modifying the chemoradiation therapy regimen. This study aimed to explore the quantitative histogram indices for treatment-response prediction of nasopharyngeal carcinoma based on diffusional kurtosis imaging compared with a standard ADC value (ADC(standard)). MATERIALS AND METHODS: Thirty-six patients with an initial diagnosis of locoregionally advanced nasopharyngeal carcinoma and diffusional kurtosis imaging acquisitions before and after neoadjuvant chemotherapy were enrolled. Patients were divided into respond-versus-nonrespond groups after neoadjuvant chemotherapy and residual-versus-nonresidual groups after radiation therapy. Histogram parameters of diffusional kurtosis imaging-derived parameters (ADC, ADC coefficient corrected by the non-Gaussain model [D], apparent kurtosis coefficient without a unit [K]) were calculated. The ADC(standard) was calculated on the basis of intravoxel incoherent movement data. The intraclass correlation coefficient, Kolmogorov-Smirnov test, Student t test or Mann-Whitney U test, and receiver operating characteristic analysis were performed. RESULTS: Most of the parameters had good-to-excellent consistency (intraclass correlation coefficient = 0.675-0.998). The pre-ADC(standard), pre-ADC (10th, 25th, 50th percentiles), pre-D (10th, 25th, 50th percentiles), and pre-K-50th were significantly different between the respond and nonrespond groups, while the pre-ADC(10th), pre-K-90th, post-ADC(50th), post-K-75th, post-K-90th, and the percentage change of parameters before and after neoadjuvant chemotherapy (ADC(50th)%) were significantly different between the residual and nonresidual groups (all P .05). Receiver operating characteristic analysis indicated that setting pre-D-50th = 0.875 x 10(-3)mm(2)/s as the cutoff value could result in optimal diagnostic performance for neoadjuvant chemotherapy response prediction (area under the curve = 0.814, sensitivity = 0.70, specificity = 0.92), while the post-K-90th = 1.035 (area under the curve = 0.829, sensitivity = 0.78, specificity = 0.72), andADC(50th)% = 0.253 (area under the curve = 0.833, sensitivity = 0.94, specificity = 0.72) were optimal for radiation therapy response prediction. CONCLUSIONS: Histogram analysis of diffusional kurtosis imaging may potentially predict the neoadjuvant chemotherapy and short-term radiation therapy response in locoregionally advanced nasopharyngeal carcinoma, therefore providing evidence for modification of the treatment regimen.
机译:背景和目的:治疗响应的预测对于规划和改性化学疗法方案是重要的。该研究旨在探讨基于扩散峰肌肤成像与标准ADC值(ADC(标准))相比的鼻咽癌癌癌治疗响应预测的定量直方图索引。材料和方法:三十六名患者初步诊断型型鼻咽癌和新辅助化疗之前和之后的扩散峰穴成像采集。患者在新辅助化疗和放射治疗后残留腹部酸组化疗和残留型 - 非乙胺组后分为响应 - 无应答组。计算扩散峰成像衍生参数的直方图参数(ADC,由非高斯模型校正的ADC系数[D],没有单位[k]的表观峰值系数。 ADC(标准)基于跨前克拉尔不连贯的运动数据计算。进行脑内相关系数,Kolmogorov-Smirnov测试,学生T测试或Mann-Whitney U测试以及接收器操作特征分析。结果:大多数参数具有良好的一致性(Intraclass相关系数= 0.675-0.998)。 ADC预见(标准),前ADC(第10,第25升,第50百分比),PR-D(第10,第25升,第50百分位数)和K-50s之间的响应和非对应群体之间具有显着差异,而ADC前(第10次),K-90,ADC后,后K-75,后K-90th,新辅助化疗前后参数的百分比变化(ADC(50th)%)在残留和非耐受组(所有P& 05)之间有显着差异。接收器操作特性分析表明,设置前D-50th = 0.875×10(-3)mm(2)/ s作为截止值可能导致Neoadjuvant化疗响应预测的最佳诊断性能(曲线下的面积= 0.814,灵敏度= 0.70,特异性= 0.92),而后k-90th = 1.035(曲线下的面积= 0.829,灵敏度= 0.78,特异性= 0.72),AndC(50th)%= 0.253(曲线下的面积= 0.833,敏感性= 0.94,特异性= 0.72)是对放射治疗响应预测的最佳选择。结论:扩散峰成像的直方图分析可能潜在地预测型鼻咽癌的新辅助化疗和短期放射治疗反应,从而为治疗方案的修饰提供了证据。

著录项

  • 来源
  • 作者单位

    Wuhan Univ Zhongnan Hosp Dept Radiol 169 Donghu Rd Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Zhongnan Hosp Dept Radiat &

    Med Oncol Wuhan Hubei Peoples R China;

    Wuhan Univ Zhongnan Hosp Dept Radiol 169 Donghu Rd Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Zhongnan Hosp Dept Radiol 169 Donghu Rd Wuhan 430071 Hubei Peoples R China;

    Wuhan Univ Zhongnan Hosp Dept Radiat &

    Med Oncol Wuhan Hubei Peoples R China;

    Wuhan Univ Zhongnan Hosp Dept Radiol 169 Donghu Rd Wuhan 430071 Hubei Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号